The International Network of Nicotine Consumer Organisations (INNCO) has alleged illegal external intervention by charitable organizations and the Philippine Food and Drug Administration during a public hearing on the Vape Bill. Members of the House of Representatives, Deputy Speaker and Southern Representative Deogracias Victor Savellano, and Nueva Ecija Representative Estrellita Suansing have called for a thorough investigation.
With the support of health advocates and the vast majority of lawmakers, the government of the Philippines has approved the "E-Cigarette Act" based on scientific evidence and the principle of saving lives. The law, also known as HB 9007 and SB2239 and commonly referred to as the Vape Bill, will be effective until July 25, 2022. It has now been officially renamed as the Republic Act 11900. This marks a significant step towards favoring public health.
Evidence has shown that an effective way to reduce harm is to help many countries lower their smoking rates, including the UK, New Zealand, France, Japan, and Sweden. For instance, smoking rates in the UK have decreased to 12.3%. In the past five years, cigarette sales in Japan have dropped by 40%. Sweden currently has the lowest smoking rate in the entire EU.
The International Network of Nicotine Consumer Organizations (INNCO) congratulates the public health advocates, harm reduction supporters, and regulatory agencies in the Philippines for their tireless efforts in promoting the new Vape bill for life-saving measures. INNCO also hopes that this harm reduction approach serves as an example for saving the lives of smokers.
Dr. Charles Gardner, Executive Director of INNCO, suggests that preventing minors from using adult products and encouraging adults to quit smoking can help mitigate the terrible deaths caused by cancer, heart disease, and lung disease.
INNCO has noticed that the 10th Conference of the Parties (COP10) of the World Health Organization Framework Convention on Tobacco Control (FCTC) will be held in Panama City in November 2023. If history repeats itself, INNCO's observer status application will be rejected, just as it was in COP9 (2021) and COP8 (2018). Most journalists will also be expelled, as in all previous FCTC COPs. Unlike the well-known open and transparent United Nations climate change "COPs", FCTC COPs are closed and opaque, excluding the voices of the 112 million people using safer nicotine alternatives. Many non-profit organizations that have obtained observer status at FCTC Conference of the Parties have obvious conflicts of interest.
Statement:
This article is compiled from third-party information and is intended for industry discussion and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is solely for the purpose of communication and research within the industry.
Due to limitations in our ability to accurately translate, the compiled article may differ in expression from the original. Please refer to the original text for accuracy.
2FIRSTS is fully aligned with the Chinese government on any domestic, Hong Kong and Macau-related, and foreign-related statements and positions.
The copyright of information compiled belongs to the original media and author, and if there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
